|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash and cash equivalents (including $51,149 and $76,857 of time deposits as of June 30, 2026 and December 31, 2025 respectively) | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Other receivables, prepaid expenses and deposit | ||||||||||||||||||||
| Tax recoverable | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| NON-CURRENT ASSETS | ||||||||||||||||||||
| Plant and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable (including $375,167 and $91 payable to related parties as of June 30, 2026 and December 31, 2025 respectively) | ||||||||||||||||||||
| Other payables and accrued liabilities | ||||||||||||||||||||
| Amount due to a director | ||||||||||||||||||||
| Finance lease liability | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Tax payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| NON- CURRENT LIABILITIES | ||||||||||||||||||||
| Finance lease liability | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Common stock, $0.0001 par value, 600,000,000 shares authorized, 206,904,585 shares issued and outstanding as of June 30, 2026 and December 31, 2025 respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
